FDA opens door to flavored vapes, alarming anti-smoking advocates
Public-health groups warn the move could reignite youth vaping after years of declines in teen e-cigarette use
‘Low T’ boom raises concerns over overdiagnosis, aggressive marketing to men
Testosterone prescriptions are surging as private clinics, influencers and social media campaigns promote “low T” as a hidden cause of fatigue, weight gain and low libido
Delays in EpiPen Use Drive Fatal Anaphylaxis in Children, New Studies Find
Having a prescription isn't enough. Patients need to have the EpiPen with them.
GLP-1 Drug Lawsuits Swell Past 3,600 Cases as Courts Tighten Proof Standards
The cases involve Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity
Federal litigation over the blockbuster class of GLP-1 drugs that includes Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity has ballooned to more than 3,600 pending cases across two multidistrict proceedings, as a federal judge moves to tighten the medical evidence